1 - 25 of 7
Number of results to display per page
TitleCreatorDate
1 Should Immunosuppressive Therapy Be Modified During a Pandemic?Marc A. Bouffard; Michael Levy; Andrew G. Lee; Gregory P. Van Stavern2021-06
2 Delayed Diagnosis of Posterior Reversible Encephalopathy Syndrome: A Case ReportRoma Pegany; Daniel J. Olson; Khalid M. Aldaas; Kevin R. Sitko2021-03
3 The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple SclerosisJodie M. Burton, MD, MSc, FRCPC; Mark S. Freedman, MSc, MD, FAAN, FANA, FRCPC2018-06
4 Tacrolimus Optic NeuropathyNailyn Rasool, MD, FRCPC; Katherine Boudreault, MD, FRCSC; Simmons Lessell, MD; Sashank Prasad, MD; Dean M. Cestari, MD2018-06
5 Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant OphthalmoplegiaRobyn M. Rautenbach, MSc; Komala Pillay, MBChB; Anthony D. N. Murray, MBChB; Jeannine M. Heckmann, PhD2017-12
6 How Neurologists and Neuro-Ophthalmologists ThinkMichael Benatar, MD, PhD2016-03
7 Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?Sui H. Wong, MRCP; Gordon T. Plant, FRCP, FRCOphth; Wayne Cornblath, MD2016-03
1 - 25 of 7